To date, more than 600 missense and nonsense mutations were discovered in the GCK gene of families suffering from MODY2 which alter glucose and ATP-binding abilities of the enzyme through directly impairing its kinetic parameters, or interfering with either structural stability or posttranslational regulation of the protein (16, 21). The gene discussed is GCK; the disease is maturity-onset diabetes of the young type 2.